Joanne Kavanagh

2.4k total citations
18 papers, 772 citations indexed

About

Joanne Kavanagh is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Joanne Kavanagh has authored 18 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Joanne Kavanagh's work include Asthma and respiratory diseases (16 papers), Respiratory and Cough-Related Research (9 papers) and Eosinophilic Esophagitis (7 papers). Joanne Kavanagh is often cited by papers focused on Asthma and respiratory diseases (16 papers), Respiratory and Cough-Related Research (9 papers) and Eosinophilic Esophagitis (7 papers). Joanne Kavanagh collaborates with scholars based in United Kingdom, Ireland and Canada. Joanne Kavanagh's co-authors include David J. Jackson, Brian D. Kent, Linda K. Green, G d’Ancona, Cris Roxas, Louise Thomson, Jaideep Dhariwal, Alexandra M. Nanzer, Mariana Fernandes and A Hearn and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Allergy.

In The Last Decade

Joanne Kavanagh

18 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joanne Kavanagh United Kingdom	13	661	546	163	130	127	18	772
Pieter‐Paul Hekking Netherlands	5	622 0.9×	506 0.9×	109 0.7×	85 0.7×	111 0.9×	9	708
Anna Rigazio United Kingdom	5	614 0.9×	513 0.9×	74 0.5×	131 1.0×	92 0.7×	6	678
Esther Helen Steveling Switzerland	11	278 0.4×	228 0.4×	202 1.2×	96 0.7×	49 0.4×	22	615
Fiona Hore‐Lacy Australia	13	479 0.7×	494 0.9×	89 0.5×	33 0.3×	78 0.6×	26	688
V. Backer Denmark	12	547 0.8×	416 0.8×	250 1.5×	89 0.7×	31 0.2×	15	715
Orn Eliasson United States	9	310 0.5×	262 0.5×	31 0.2×	36 0.3×	26 0.2×	12	472
Nora Drick Germany	10	205 0.3×	186 0.3×	66 0.4×	52 0.4×	54 0.4×	35	363
G. Pietri United States	11	203 0.3×	123 0.2×	79 0.5×	17 0.1×	98 0.8×	24	399
Gustavo Falbo Wandalsen Brazil	13	197 0.3×	222 0.4×	85 0.5×	55 0.4×	34 0.3×	62	447
Mary DiMaio United States	8	223 0.3×	227 0.4×	23 0.1×	118 0.9×	23 0.2×	13	549

Countries citing papers authored by Joanne Kavanagh

Since Specialization

Citations

This map shows the geographic impact of Joanne Kavanagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Kavanagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Kavanagh more than expected).

Fields of papers citing papers by Joanne Kavanagh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Kavanagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Kavanagh. The network helps show where Joanne Kavanagh may publish in the future.

Co-authorship network of co-authors of Joanne Kavanagh

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Kavanagh. A scholar is included among the top collaborators of Joanne Kavanagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Kavanagh. Joanne Kavanagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

d’Ancona, G, Joanne Kavanagh, Jaideep Dhariwal, et al.. (2021). Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma. Allergy. 76(7). 2238–2241. 18 indexed citations

Hearn, A, Joanne Kavanagh, G d’Ancona, et al.. (2021). Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy. European Respiratory Journal. 57(6). 2100166–2100166. 3 indexed citations

Kavanagh, Joanne, A Hearn, & David J. Jackson. (2021). A pragmatic guide to choosing biologic therapies in severe asthma. Breathe. 17(4). 210144–210144. 32 indexed citations

Dhariwal, Jaideep, A Hearn, Joanne Kavanagh, et al.. (2021). Real-World Effectiveness of Anti–IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization. The Journal of Allergy and Clinical Immunology In Practice. 9(6). 2315–2320.e1. 30 indexed citations

Hearn, A, Joanne Kavanagh, G d’Ancona, et al.. (2021). The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma. The Journal of Allergy and Clinical Immunology In Practice. 9(5). 2093–2096.e1. 49 indexed citations

Nanzer, Alexandra M., Jaideep Dhariwal, Joanne Kavanagh, et al.. (2020). Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis. ERJ Open Research. 6(4). 451–2020. 31 indexed citations

d’Ancona, G, Joanne Kavanagh, Cris Roxas, et al.. (2020). Adherence to inhaled corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma. European Respiratory Journal. 55(5). 1902259–1902259. 57 indexed citations

Kent, Brian D., G d’Ancona, Mariana Fernandes, et al.. (2020). Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis. ERJ Open Research. 6(1). 311–2019. 26 indexed citations

Kavanagh, Joanne, A Hearn, G d’Ancona, et al.. (2020). Benralizumab after sub‐optimal response to mepolizumab in severe eosinophilic asthma. Allergy. 76(6). 1890–1893. 35 indexed citations

10.

Kavanagh, Joanne, A Hearn, Jaideep Dhariwal, et al.. (2020). Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma. CHEST Journal. 159(2). 496–506. 187 indexed citations

11.

Kavanagh, Joanne, G d’Ancona, Maria Elstad, et al.. (2020). Real-World Effectiveness and the Characteristics of a “Super-Responder” to Mepolizumab in Severe Eosinophilic Asthma. CHEST Journal. 158(2). 491–500. 126 indexed citations

12.

Kavanagh, Joanne, Cris Roxas, Linda K. Green, et al.. (2020). Super-responder analysis and real-world one year effectiveness of benralizumab in severe eosinophilic asthma. 2261–2261. 3 indexed citations

13.

Kavanagh, Joanne, A Hearn, Cris Roxas, et al.. (2020). Relationship between baseline fraction of exhaled nitric oxide (FeNO) and response to anti-IL-5/5R therapies in severe eosinophilic asthma (SEA). 2253–2253. 1 indexed citations

14.

Kavanagh, Joanne, David J. Jackson, & Brian D. Kent. (2019). Over- and under-diagnosis in asthma. Breathe. 15(1). e20–e27. 90 indexed citations

15.

Myall, Katherine, Joanne Kavanagh, & Surinder S. Birring. (2019). Idiopathic pulmonary fibrosis-associated cough: Mechanisms and management. Pulmonary Pharmacology & Therapeutics. 56. 100–103. 7 indexed citations

16.

Jackson, David J., Cris Roxas, Mariana Fernandes, et al.. (2019). Real-world oral glucocorticoid-sparing effect of benralizumab in severe asthma. PA2527–PA2527. 1 indexed citations

17.

Kavanagh, Joanne, David J. Jackson, & Brian D. Kent. (2018). Sleep and asthma. Current Opinion in Pulmonary Medicine. 24(6). 569–573. 61 indexed citations

18.

Birring, Surinder S., Joanne Kavanagh, Kefang Lai, & Anne B. Chang. (2015). Adult and paediatric cough guidelines: Ready for an overhaul?. Pulmonary Pharmacology & Therapeutics. 35. 137–144. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact